@SenMcConnell@RepGuthrie A new poll shows voters are focused on what hits their wallets hardest: health insurance premiums and out-of-pocket costs. 66% want candidates committed to lowering premiums. That's the priority voters are sending.
https://t.co/krnk4X0peg
Most Favored Nation pricing doesn't lower costs, it lowers innovation. Fewer resources for R&D means fewer future vaccines and cures. During National Immunization Awareness Month, protect what makes new immunizations possible. @SenMcConnell@RepAndyBarr
https://t.co/YkLy9UeHhZ
@RepJamesComer@SenMcConnell Medicine innovation is giving people longer, healthier lives. Don’t support MFN policies that could slow down the next breakthrough
https://t.co/fKHi48ae4a
@SenMcConnell 340B providers generated $1B in profits from state employee health plans nationwide. Add teachers and local plans? $1.8B. That’s not savings.
https://t.co/XMYmUJbmPy
Most Favored Nation drug pricing sounds simple, but it would tie U.S. prices to foreign government controls and threaten investment in future cures. @RepJamesComer@SenMcConnell
https://t.co/4BW14YBrBP
Kentucky families can't afford policies that risk access. MFN-style foreign price controls would only make things worse - PBM reform is the serious solution. @SenMcConnell
Studies continue to find insurer and PBM policies preventing care @RepGuthrie@SenMcConnell why hasn’t Congress passed legislation yet?
https://t.co/rmpmRpK6QE
The job of pharmacy benefit managers is to reduce drug costs. Instead, they steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions in hidden fees, The New York Times found. https://t.co/cqsX8IBiSl
The job of pharmacy benefit managers is to reduce drug costs. Instead, they steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions in hidden fees, The New York Times found. https://t.co/cqsX8IBiSl
How can PBMs say they help patients and then pocket savings meant for low-income patients? Lawmakers in Washington need to protect patients and rein in PBMs unfair practices. https://t.co/0B3E1ZR7h9 (https://t.co/ofegbJY4tW)
I’m disappointed that Congress failed to get PBM reform done. @JamesComer please support bipartisan measures like the DRUG Act and deliver for patients now.
PBMs are blocking access to critical care for people across Kentucky. @RepJamesComer we need commonsense bills like the DRUG Act passed now. #endPBMAbuse
The Biden Administration says it wants to end cancer as we know it through the Moonshot program. But misguided policies from the Administration could jeopardize the mission, write R&D leaders. Read more: https://t.co/0DnCS0PhIA
What @WhiteHouse isn't telling you: They're giving a single government agency power to arbitrarily set medicine prices with little accountability, oversight or input from patients & their doctors—with consequences long after this administration is gone. https://t.co/t5UeVnWftr
SHEIN'S Hot Deals
This price is as low as it gets, shop quick!
FREE ShippinSHEIN'S Hot Deals
This price is as low as it gets, shop quick!
FREE ShippinSHEIN'S Hot Deals
This price is as low as it gets, shop quick!
FREE Shipping